FOETAL MEGACYSTIS

This adverse event was reported 44 times

FOETAL MEGACYSTIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MEBENDAZOLE 6 0.0076
1 DEXMEDETOMIDINE 2 0.0006
2 ALBENDAZOLE 1 0.0005
3 DEXMEDETOMIDINE HYDROCHLORIDE 1 0.0003
4 AMOXICILLIN 13 0.0002
5 ICATIBANT ACETATE 1 0.0002
6 LEVETIRACETAM ORAL 13 0.0002
7 LEVETIRACETAM INJECTION 13 0.0002
8 DARUNAVIR 600 MG 1 0.0002
9 LEVOTHYROXINE SODIUM ANHYDROUS 16 0.0002
See all drugs enriched for association with FOETAL MEGACYSTIS

FOETAL MEGACYSTIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 7 0.0024
1 General Anesthetic [EPC] 3 0.0001
2 Opioid Agonist [EPC] 13 0.0000
3 Protease Inhibitor [EPC] 2 0.0000
4 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
5 Nitroimidazole Antimicrobial [EPC] 1 0.0000
6 Mood Stabilizer [EPC] 2 0.0000
7 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
8 Vitamin D [EPC] 2 0.0000
9 Vitamin B12 [EPC] 2 0.0000
See all drug classes enriched for association with FOETAL MEGACYSTIS